An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment.

Fisher S., Patel S., Bagci P., Kooby D., El-Rayes B., Staley C., ...Daha Fazla

Cancer, cilt.119, ss.445-53, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 119
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1002/cncr.27619
  • Dergi Adı: Cancer
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.445-53
  • Anahtar Kelimeler: excision cross-complementing gene-1, ribonucleotide reductase subunit 1, ribonucleotide reductase subunit 2, human equilibrative nucleoside transporter-1, pancreas cancer, biomarkers, 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP, CELL LUNG-CANCER, ADJUVANT CHEMOTHERAPY, PREDICTS SURVIVAL, GEMCITABINE, TRIAL, PHARMACOGENETICS, CHEMOSENSITIVITY, CYTOTOXICITY, INHIBITION
  • Marmara Üniversitesi Adresli: Hayır